• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    3/31/25 4:06:33 PM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email
    hum-20250326
    0000049071false00000490712025-03-262025-03-26

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K 
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): March 31, 2025 (March 26, 2025)
    Humana Inc. 
    (Exact name of registrant as specified in its charter)
    Delaware001-0597561-0647538
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    500 W. Main Street, Louisville, Kentucky 40202 
    (Address of principal executive offices, and Zip Code)
    502-580-1000 
    Registrant’s telephone number, including area code
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common StockHUMNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 1.01.     Entry into a Material Definitive Agreement.
    Underwriting Agreement
    On March 26, 2025, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters an additional $250 million aggregate principal amount of its 5.375% Senior Notes due 2031 (the “Additional 2031 Notes”), in accordance with the terms and conditions set forth in the Underwriting Agreement. The Additional 2031 Notes are an additional issuance of the 5.375% Senior Notes due 2031 that the Company issued in an aggregate principal amount of $1.25 billion on March 13, 2024 (the “Existing 2031 Notes” and, together with the Additional 2031 Notes, the “Notes”). The Additional 2031 Notes are fungible with the Existing 2031 Notes and form a single series with the Existing 2031 Notes. The Additional 2031 Notes have terms that are identical to the terms of the Existing 2031 Notes (except for the issuance date and issuance price) and have the same ISIN and CUSIP numbers as the Existing 2031 Notes. The Additional 2031 Notes were sold at a public offering price of 99.941% of the aggregate principal amount thereof, plus accrued interest from October 15, 2024 (the most recent interest payment date) to but excluding the settlement date. Following the completion of the offering, together with the previously issued $1.25 billion in aggregate principal amount of the Existing 2031 Notes, the total outstanding aggregate principal amount of the Notes is $1.5 billion.
    The sale of the Additional 2031 Notes has been registered with the Securities and Exchange Commission (the “Commission”) in a registration statement on Form S-3, File No. 333-277734 (the “Registration Statement”). The terms of the Additional 2031 Notes are described in the Company’s Prospectus dated March 7, 2024, as supplemented by a final Prospectus Supplement dated March 26, 2025 as filed with the Commission on March 27, 2025, pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended.
    The Underwriters and their affiliates have performed commercial banking, investment banking, corporate trust and advisory services for the Company from time to time for which they have received customary fees and expenses. The Underwriters and their affiliates may, from time to time, engage in transactions with and perform services for the Company in the ordinary course of their business. In addition, certain affiliates of the Underwriters are lenders under the Company’s revolving credit facility and 364-day credit facility, and the Underwriters or their affiliates may hold the Company’s existing senior notes for their own accounts.
    The Company estimates that the net proceeds from the sale of the Additional 2031 Notes, after deducting the Underwriters’ discounts and commissions and estimated offering expenses, will be approximately $247 million. The Company intends to use the net proceeds from the Additional 2031 Notes offerings for general corporate purposes, which may include the repayment of existing indebtedness.
    A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference herein. The description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.
    Indenture, Twenty-Eighth Supplemental Indenture
    On March 31, 2025, the Company completed a public offering of the Additional 2031 Notes. The Additional 2031 Notes are an additional issuance of the Existing 2031 Notes under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the “Trustee”) (the “Original Indenture”), as supplemented by the twenty-eighth supplemental indenture, dated as of March 13, 2024, by and between the Company and the Trustee relating to the Notes (the “Twenty-Eighth Supplemental Indenture” and, together with the Original Indenture, the “Indenture”).
    Pursuant to the terms of the Indenture, the Additional 2031 Notes are unsecured senior obligations of the Company and rank equally with all of the Company’s other unsecured, unsubordinated indebtedness, including the



    Existing 2031 Notes. The Additional 2031 Notes bear interest at an annual rate of 5.375%. Interest on the Additional 2031 Notes is payable by the Company on April 15 and October 15 of each year, beginning on April 15, 2025. The Additional 2031 Notes mature on April 15, 2031.
    A copy of the Original Indenture is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Twenty-Eighth Supplemental Indenture is filed as Exhibit 4.2 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 5.375% Senior Notes due 2031 is filed as Exhibit 4.3 to this Current Report on Form 8-K and is incorporated by reference herein. The descriptions of the material terms of the Original Indenture, the Twenty-Eighth Supplemental Indenture and the Additional 2031 Notes are qualified in their entirety by reference to such exhibits. In addition, the legal opinion of Fried, Frank, Harris, Shriver & Jacobson LLP related to the Additional 2031 Notes is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.
    The Trustee has also been appointed registrar and paying agent with regard to the Additional 2031 Notes and serves the same roles with respect to certain other series of the Company’s outstanding senior notes. An affiliate of the Trustee is also a lender under the Company’s revolving credit facility and 364-day credit facility.
    Item 2.03.     Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.
    The information required by Item 2.03 contained under the heading “Indenture, Twenty-Eighth Supplemental Indenture” in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.



    Item 9.01.    Financial Statements and Exhibits.
    (d) Exhibits:
    Exhibit No.
    Description
    1.1
    Underwriting Agreement, dated March 26, 2025, among the Company and J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters.
    4.1
    Indenture, dated as of August 5, 2003, by and between the Company and The Bank of New York, as trustee (incorporated herein by reference to Exhibit 4.1 to Humana Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003).
    4.2
    Twenty-Eighth Supplemental Indenture, dated March 13, 2024, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.’s Current Report on Form 8-K filed on March 13, 2024).
    4.3
    Form of 5.375% Senior Notes due 2031 (incorporated herein by reference to Exhibit 4.3 to Humana Inc.’s Current Report on Form 8-K filed on March 13, 2024).
    5.1
    Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP.
    23.1
    Consent of Fried, Frank, Harris, Shriver & Jacobson LLP (included in Exhibit 5.1).
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).

    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
    HUMANA INC.
    BY:/s/ John-Paul W. Felter
    John-Paul W. Felter
    Senior Vice President, Chief Accounting Officer and Controller
    (Principal Accounting Officer)
    Dated: March 31, 2025

    Get the next $HUM alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    10/7/2024$402.00 → $261.00Buy → Hold
    TD Cowen
    10/7/2024$519.00 → $253.00Buy → Hold
    Jefferies
    10/3/2024$392.00 → $274.00Overweight → Neutral
    Piper Sandler
    10/2/2024$376.00 → $247.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Humana upgraded by Raymond James with a new price target

      Raymond James upgraded Humana from Mkt Perform to Outperform and set a new price target of $315.00

      5/1/25 7:42:13 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana upgraded by BofA Securities with a new price target

      BofA Securities upgraded Humana from Underperform to Neutral and set a new price target of $308.00 from $247.00 previously

      11/6/24 8:21:46 AM ET
      $HUM
      Medical Specialities
      Health Care
    • KeyBanc Capital Markets initiated coverage on Humana

      KeyBanc Capital Markets initiated coverage of Humana with a rating of Sector Weight

      10/11/24 7:47:34 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Villages Health ("TVH") Announces Strategic Restructuring and Agreement to be Acquired by CenterWell

      ORLANDO, Fla., July 3, 2025 /PRNewswire/ -- The Villages Health ("TVH"), the trusted healthcare system for The Villages retirement community in Florida, today announced that it is proceeding with a strategic restructuring to preserve the business's day-to-day operations and further enhance patient care. As part of this strategy, TVH today voluntarily filed for bankruptcy in the United States Bankruptcy Court for the Middle District of Florida, Orlando Division, under Chapter 11 of the U.S. Bankruptcy Code, and filed customary First Day Motions seeking relief on an immediate basis to minimize any adverse delays or disruptions to its daily operations.

      7/3/25 10:02:00 PM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Launches Medicaid Plan in Virginia

      Virginia Cardinal Care beneficiaries are now able to choose Humana Healthy Horizons for their health care coverage Humana Healthy Horizons is now a Medicaid plan option for Virginians covered by Virginia Cardinal Care. "At Humana, we put our members' health first, and we are committed to improving the holistic well-being of the communities we serve. We have the privilege of serving Medicare Advantage and TRICARE members throughout Virginia, and we are honored to expand our human-centered care to Virginians covered by Cardinal Care," said Humana Healthy Horizons President John Barger. "By providing Medicaid coverage under Cardinal Care, we have the opportunity to deliver innovative solut

      7/2/25 12:59:00 PM ET
      $HUM
      Medical Specialities
      Health Care
    • National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

      The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

      6/25/25 9:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    SEC Filings

    See more
    • SEC Form 11-K filed by Humana Inc.

      11-K - HUMANA INC (0000049071) (Filer)

      6/17/25 3:52:50 PM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form 11-K filed by Humana Inc.

      11-K - HUMANA INC (0000049071) (Filer)

      6/17/25 3:49:20 PM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - HUMANA INC (0000049071) (Filer)

      6/2/25 7:30:12 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

      4 - HUMANA INC (0000049071) (Issuer)

      5/16/25 4:48:13 PM ET
      $HUM
      Medical Specialities
      Health Care
    • Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

      4 - HUMANA INC (0000049071) (Issuer)

      2/21/24 10:37:23 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Hilzinger Kurt J

      4 - HUMANA INC (0000049071) (Issuer)

      7/2/25 4:18:17 PM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Smith Gordon

      4 - HUMANA INC (0000049071) (Issuer)

      7/2/25 2:21:21 PM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Feinberg David T

      4 - HUMANA INC (0000049071) (Issuer)

      7/2/25 11:53:31 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    See more
    • National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

      The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

      6/25/25 9:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

      Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

      6/18/25 8:30:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Announces CFO Transition

      Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that Celeste Mellet will be appointed to succeed Susan Diamond as Chief Financial Officer (CFO), effective January 11, 2025. Diamond is stepping down after a successful 18-year career at Humana, including over three years as CFO, and will serve in an advisory role through the end of 2025 to ensure a smooth transition. "On behalf of the entire Board and management team, I want to extend my thanks to Susan for her leadership as CFO and in prior roles during her nearly two decades at Humana," said Jim Rechtin, Humana's President and Chief Executive Officer. "Susan's contributions spanned across our Medicare, Home So

      12/3/24 8:05:00 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Humana Inc. (Amendment)

      SC 13G/A - HUMANA INC (0000049071) (Subject)

      2/16/24 4:29:43 PM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Humana Inc. (Amendment)

      SC 13G/A - HUMANA INC (0000049071) (Subject)

      2/14/24 10:02:59 AM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Humana Inc. (Amendment)

      SC 13G/A - HUMANA INC (0000049071) (Subject)

      2/13/24 5:06:27 PM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Financials

    Live finance-specific insights

    See more
    • Humana Reports First Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted Financial Guidance

      Reports 1Q25 earnings per share (EPS) of $10.30 on a GAAP basis, Adjusted EPS of $11.58 1Q25 Insurance segment benefit ratio of 87.4 percent, in line with the company's previously disclosed expectation of 'approximately 87.5 percent' Affirms Adjusted FY 2025 EPS guidance of 'approximately $16.25'; while revising GAAP EPS to 'approximately $14.68' from the previous estimate of 'approximately $15.88' Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent Affirms expected individual Medicare Advantage annual membership decline of approximately 550,000, inclusive of the impact of exiting certain unprofitable plans and counties Remains confident

      4/30/25 6:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Board Declares Payment of Quarterly Dividend to Stockholders

      Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 25, 2025 to stockholders of record as of the close of business on June 27, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military serv

      4/17/25 6:30:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Inc. Announces Dates for First Quarter 2025 Earnings and June Investor Conference

      Humana Inc. (NYSE:HUM) will release financial results for the first quarter 2025 (1Q25) and host a live question-and-answer session on Wednesday, April 30, 2025. Additionally, the company will host an Investor Conference on Monday, June 16, 2025. 1Q25 Earnings Humana will release its 1Q25 financial results, as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 30, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. A webcast of the 1Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gc

      4/3/25 4:15:00 PM ET
      $HUM
      Medical Specialities
      Health Care